Gocovri

Generic name:amantadine [ a-MAN-ta-deen ]
Drug class:Dopaminergic antiparkinsonism agents

Medically reviewed by Judith Stewart, BPharm. Last updated on Feb 4, 2021.

What is Gocovri?

Gocovri is a prescription medicine containing amantadine.

Gocovri is used to treat dyskinesia (sudden uncontrolled movements) in people with Parkinson's disease who are treated with levodopa or levodopa plus other medicines that increase the effects of dopamine in the brain.

Gocovri is also used with the medicines levodopa and carbidopa in people with Parkinson’s disease who are having “off” episodes.

Gocovri may also be used for purposes not listed in this medication guide.

Warnings

You should not use Gocovri if you received a nasal flu vaccine in the past 14 days.

Do not receive a nasal flu vaccine while taking Gocovri, and for at least 48 hours after your last dose.

Before taking this medicine

You should not use Gocovri if you are allergic to amantadine, or if:

• you have severe kidney disease; or

• you have received a "live" nasal flu vaccine (FluMist) within the past 14 days.

Tell your doctor if you have ever had:

• kidney disease;

• daytime drowsiness (caused by a sleep disorder or taking certain medicines);

• congestive heart failure;

• eczema;

• glaucoma;

• liver disease;

• a seizure;

• low blood pressure, fainting spells;

• alcoholism or drug addiction; or

• mental illness, psychosis, or suicidal thoughts or actions.

People with Parkinson's disease may have a higher risk of <...